Group 1 - Viking Therapeutics (NASDAQ: VKTX) has gained attention in the drug obesity sector, indicating a growing interest in this market [1] - The analysis focuses on business models, earnings performance, and competitive positioning within the industry [1] - The author emphasizes the importance of fundamental analysis and long-term growth, particularly in sectors like AI, fintech, and technology [1] Group 2 - The article does not provide any specific financial data or performance metrics related to Viking Therapeutics or the broader drug obesity market [1]